Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhe Lin

Showing results (311-320 of 352) with videos related to

Pageof 36
Sort By:
Plos One|November 19, 2013
Radiofrequency ablation is superior to ethanol injection in early-stage hepatocellular carcinoma irrespective of tumor sizeZhong-Zhe Lin, Wen-Yi Shau, Chiun Hsu, et al.
The Oncologist|April 10, 2020
A Multicenter Phase II Study of Second-Line Axitinib for Patients with Advanced Hepatocellular Carcinoma Failing First-Line Sorafenib MonotherapyZhong-Zhe Lin, Bang-Bin Chen, Yi-Ping Hung, et al.
European Journal of Cancer (Oxford, England : 1990)|July 7, 2019
Incidence of hepatitis B reactivation during epidermal growth factor receptor tyrosine kinase inhibitor treatment in non-small-cell lung cancer patientsZong-Han Yao, Wei-Yu Liao, Chao-Chi Ho, et al.
The Oncologist|May 17, 2017
Real-World Data on Prognostic Factors for Overall Survival in EGFR Mutation-Positive Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line GefitinibZong-Han Yao, Wei-Yu Liao, Chao-Chi Ho, et al.
Frontiers in Bioscience (Landmark Edition)|December 6, 2025
Sodium Alginate Microgel-Wrapped Primary Human Peritoneal Mesothelial Cells for the Treatment of Peritoneal Fibrosis Caused by Dialysis via the POSTN/NF-κB/CXCL8 PathwayShuqing Ma, Chunyan Qiu, Jue Zhang, et al.
Cancers|October 23, 2021
Limited Predictive or Prognostic Role of Tumor-Infiltrating Tissue-Resident Memory CD8 T Cells in Patients with Hepatocellular Carcinoma Receiving ImmunotherapyYing-Chun Shen, Ching-Ping Yeh, Yung-Ming Jeng, et al.
Computational and Structural Biotechnology Journal|January 13, 2022
miR-4759 suppresses breast cancer through immune checkpoint blockadeYou-Zhe Lin, Shu-Hsuan Liu, Wan-Rong Wu, et al.
Computational and Structural Biotechnology Journal|December 9, 2025
ImmiR: A database of microRNAs associated with immune checkpoints and infiltratesWen-Jen Lin, Yu-De Wang, Chia-Hsin Liu, et al.
European Radiology|July 21, 2022
Sarcopenia and myosteatosis are associated with survival in patients receiving immunotherapy for advanced hepatocellular carcinomaBang-Bin Chen, Po-Chin Liang, Tiffany Ting-Fang Shih, et al.
Journal of Hepatocellular Carcinoma|June 10, 2024
Changes in Posttreatment Spleen Volume Associated with Immunotherapy Outcomes for Advanced Hepatocellular CarcinomaBang-Bin Chen, Po-Chin Liang, Tiffany Ting-Fang Shih, et al.
Pageof 36

Showing results (311-320 of 352) with videos related to

Sort By:
Pageof 36
Plos One|November 19, 2013
Radiofrequency ablation is superior to ethanol injection in early-stage hepatocellular carcinoma irrespective of tumor sizeZhong-Zhe Lin, Wen-Yi Shau, Chiun Hsu, et al.
The Oncologist|April 10, 2020
A Multicenter Phase II Study of Second-Line Axitinib for Patients with Advanced Hepatocellular Carcinoma Failing First-Line Sorafenib MonotherapyZhong-Zhe Lin, Bang-Bin Chen, Yi-Ping Hung, et al.
European Journal of Cancer (Oxford, England : 1990)|July 7, 2019
Incidence of hepatitis B reactivation during epidermal growth factor receptor tyrosine kinase inhibitor treatment in non-small-cell lung cancer patientsZong-Han Yao, Wei-Yu Liao, Chao-Chi Ho, et al.
The Oncologist|May 17, 2017
Real-World Data on Prognostic Factors for Overall Survival in EGFR Mutation-Positive Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line GefitinibZong-Han Yao, Wei-Yu Liao, Chao-Chi Ho, et al.
Frontiers in Bioscience (Landmark Edition)|December 6, 2025
Sodium Alginate Microgel-Wrapped Primary Human Peritoneal Mesothelial Cells for the Treatment of Peritoneal Fibrosis Caused by Dialysis via the POSTN/NF-κB/CXCL8 PathwayShuqing Ma, Chunyan Qiu, Jue Zhang, et al.
Cancers|October 23, 2021
Limited Predictive or Prognostic Role of Tumor-Infiltrating Tissue-Resident Memory CD8 T Cells in Patients with Hepatocellular Carcinoma Receiving ImmunotherapyYing-Chun Shen, Ching-Ping Yeh, Yung-Ming Jeng, et al.
Computational and Structural Biotechnology Journal|January 13, 2022
miR-4759 suppresses breast cancer through immune checkpoint blockadeYou-Zhe Lin, Shu-Hsuan Liu, Wan-Rong Wu, et al.
Computational and Structural Biotechnology Journal|December 9, 2025
ImmiR: A database of microRNAs associated with immune checkpoints and infiltratesWen-Jen Lin, Yu-De Wang, Chia-Hsin Liu, et al.
European Radiology|July 21, 2022
Sarcopenia and myosteatosis are associated with survival in patients receiving immunotherapy for advanced hepatocellular carcinomaBang-Bin Chen, Po-Chin Liang, Tiffany Ting-Fang Shih, et al.
Journal of Hepatocellular Carcinoma|June 10, 2024
Changes in Posttreatment Spleen Volume Associated with Immunotherapy Outcomes for Advanced Hepatocellular CarcinomaBang-Bin Chen, Po-Chin Liang, Tiffany Ting-Fang Shih, et al.
Pageof 36